sample preparation assignment
Embed Size (px)
TRANSCRIPT
-
8/12/2019 Sample Preparation Assignment
1/6
I. BLOOD SAMPLE1. SAMPLE
Matrix: blood
Sample preparation: Condition a Bond-Elut C18 column with 2 volumes MeOH then 2
volumes water. Add 1 mL serum then 200 L 700 ng/mL promazine in MeOHrO. 1 M HCl
13:87 to each column, wash with 2 volumes water, wash with 2 volumes 0.1 M acetic acid,
wash with MeOH/water, add 200 (JLL 10 mM ammonium acetate in MeOH, wait for 30 s,
elute with vacuum, repeat elution process two more times. Combine eluates and evaporate
them to dryness at 56-8 under compressed air. Reconstitute with 200 L mobile
phase, vortex 10 s, inject 75-100 L aliquot. (MeOH/water was 500 mL MeOH:water 65:
35 plus 25 L concentrated HCl.)
HPLCVARIABLES
Column: 250 X 4.6 5 jim Supelco silica
Mobile phase: EtOH:MeCN:t-butylamine 98:2:0.05 (Mix 1 gallon EtOH with 77 mL MeCN
and 1.9 mL t-butylamine.)
Flow rate: 2
Injection volume: 75-100
Detector: UV 254
CHROMATOGRAM
Retention time: 3.6, 3.3 (cis isomer)
Internal standard: promazine (5.2)
Limit of detection: 2 ng/mL
OTHER SUBSTANCES
Extracted: amitriptyline, desipramine, desmethyldoxepin, imipramine, nortriptyline,
protriptyline
Simultaneous: N-acetylprocainamide, procainamide, zimeldine, morphine, codeine,
trifluoperazine, 2-hydroxydesipramine, desmethylchlordiazepoxide, buprion, diazepam,
demoxepam, chlordiazepoxide, propoxyphene, dextropropoxyphene, cocaine, oxapam,
trimipramine, mianserin, trimeprazine, loxepin, fluphenazine, methadone, trifluopromazine,
phenteramine, chlorimipramine
Noninterfering: thiopropazineInterfering: thioridazine, hydroxyamoxapine, meperidine, chlorpromazine, disopyramide,
-
8/12/2019 Sample Preparation Assignment
2/6
amphetamine, 2-hydroxyimipramine, iprindole, pyrilamine, promethazine, prolixin,
amoxapine
KEYWORDS
serum; normal phase
REFERENCE
Beierle,F.A.; Hubbard,R-W. Liquid chromatographic separation of antidepressant drugs: I.
Tricyclics, Ther.DrugMonit, 1983, 5, 279-292.
2. SAMPLEMatrix: blood
Sample preparation: 1 mL Serum + 1 mL 450 mM NaOH + 5 mL hexane:isopropanol 95:
5, shake for 5 min, centrifuge. Remove 4 mL of the organic layer and add it to 50 L 200
mM HCl, shake for 2 min, centrifuge. Inject a 20 L aliquot of the aqueous layer.
HPLC VARIABLES
Column: 100 X 3 octyl CP-tm-Spher C8 glass column (Chrompack)
Mobile phase: MeCN:500 mM NaH2PO4 35:65 adjusted to pH 2.2 with phosphoric acidFlow rate: 0.8
Injection volume: 20
Detector: UV 210
CHROMATOGRAM
Retention time: 3.3
Limit of detection: 10 ng/mL
OTHER SUBSTANCES
Simultaneous: nortriptyline, amitriptyline
KEY WORDS
serum
REFERENCE
-
8/12/2019 Sample Preparation Assignment
3/6
Van Damme,M.; Molle,L.; Abi Khalil,F. Useful sample handlings for reversed phase high
performance liquid chromatography in emergency toxicology, J.Toxicol.Clin.ToxicoL, 1985,
23, 589-614.
3. SAMPLEMatrix: blood
Sample preparation: Condition a 1 mL Analytichem cyanopropyl SPE cartridge with 1
mL water and 1 mL MeOH, do not allow to dry. Add 1 mL serum + 250 (xL 0.2 g/mL
imipramine in 50 mM sodium n-heptanesulfonic acid to the SPE cartridge, wash with 1
mL water, 1 mL MeOH:water 50:50, air dry cartridge, elute with 1 mL MeOH:triethylamine
99.2:0.8, evaporate eluate to dryness under a stream of nitrogen at 40, reconstitute
residue with 250 L mobile phase, inject a 50 L aliquot.
HPLC VARIABLES
Column: 150 X 4.6 5(xm Spherisorb cyanopropyl
Mobile phase: MeOH:20 mM phosphoric acid containing 0.05% N,N-diethyloctylamine 55:
45, pH was 2.4
Flow rate: 1.5
Injection volume: 50Detector: UV 214
CHROMATOGRAM
Retention time: 6
Internal standard: imipramine (9)
Limit of detection: 2 ng/mL
OTHER SUBSTANCES
Simultaneous: metabolites
KEYWORDS
serum; SPE
REFERENCE
-
8/12/2019 Sample Preparation Assignment
4/6
Emm,T.; Lesko,L.J.; Perkal,M.B. Simultaneous determination of doxepin and nordoxepin in
serum using high-performance liquid chromatography,J.Chromatogr., 1987,419, 445-451.
II. URINE BLOOD SAMPLE1. SAMPLE
Matrix: blood, urine
Sample preparation: Add 500 L 3 M ammonia solution and 7 mL n-pentane:isopropanol
95:5 to 2 mL plasma containing 200 ng/mL nortriptyline or 2 mL urine containing 400 ng/mL
nortriptyline, shake in an overhead shaker for 20 min, let stand for 10 min. Transfer the
upper organic layer to a tube containing 1 mL 100 mM HCl, shake for 20 min, let stand for 5
min. Aspirate the organic phase to waste, wash the remaining aqueous layer with 3 mL
pentane by shaking for 10 min. Add 500 L3 M ammonia solution and 6 mL a-
pentane:isopropanol 95:5 to the washed aqueous layer, shake for 20 min, evaporate the
organic layer under a stream of nitrogen at 65, reconstitute the residue with 160 L mobile
phase, inject a 60 L aliquot.
HPLC VARIABLES
Column: 150 X 4.5 3 m Spherisorb silica
Mobile phase: MeOH:hexane:nonylamine 5:95:0.3
Flow rate: 1
Injection volume: 60
Detector: UV 254
CHROMATOGRAM
Retention time: 4.0 (cis), 4.5 (trans)
Internal standard: nortriptyline (10)
OTHER SUBSTANCES
Extracted: metabolites, N-desmethyldoxepin
KEYWORDS
dog; human; plasma; normal phase
REFERENCE
-
8/12/2019 Sample Preparation Assignment
5/6
Yan,J.; Hubbard,J.W.; McKay,G.; Midha,K.K. Stereoselective and simultaneous measurement
of cis- and trans-isomers of doxepin and N-desmethyldoxepin in plasma or urine by high-
performance liquid chromatography,J.Chromatogr.B, 1997, 691, 131-138.
III.HAIR SAMPLE1. SAMPLE
Matrix: hair
Sample preparation: Wash hair in water, rinse 3 times with MeOH, dry, weigh. 5-25 mg
Washed hair + 1 mL 1 M NaOH, heat at 70 for 30 min, adjust pH to 9.5-10. 1 mL Extract + 1
|xg protriptyline + 1 mL water + 1 mL 200 mM sodium carbonate buffer, mix, extract with
hexane:butanol 95:5 for 20 min. Remove the organic layer and add it to 100 JULL 0.2%
orthophosphoric acid, mix for 20 min, inject a 30 JULL aliquot of the aqueous layer.
HPLC VARIABLES
Guard column: 15 X 3.2 7 u-m Newguard RP-18
Column: 100 X 4.6 Spheri-5 RP-C18
Mobile phase: MeCN:buffer 40:60 (Buffer was 1.2 L 100 mM pH 7.0 NaH2PO4 + 30 Ml
diethylamine.)
Flow rate: 2
Injection volume: 30
Detector: UV 214
CHROMATOGRAM
Internal standard: protriptyline (4)
OTHER SUBSTANCES
Extracted: amitriptyline, clomipramine, desipramine, dothiepin, haloperidol, imipramine,
mianserin, nortriptyline
KEYWORDS
may be interferences
IV.SOLUTION SAMPLE1.
SAMPLEMatrix: solutions
-
8/12/2019 Sample Preparation Assignment
6/6
HPLC VARIABLES
Guard column: 30 X 2.1 Spheri-5 RP-8
Column: 220 X 2.1 Spheri-5 RP-8
Mobile phase: Gradient. A was 0.08% diethylamine and 0.09% phosphoric acid in water, pH
2.3. B was MeCN:water 90:10 containing 0.08% diethylamine and 0.09% phosphoric acid.
A:B 95:5 for 2 min, to 0:100 over 15 min (?), maintain at 0:100 for 5 min.
Column temperature: 50
Flow rate: 0.5
Detector: UV 200
CHROMATOGRAM
Retention time: 13
OTHER SUBSTANCES
Simultaneous: desmethyldoxepin, desipramine, nortriptyline, imipramine, amitriptyline
Also analyzed: amphetamine, chlordiazepoxide, chlorpromazine, desalkylflurazepam,
diazepam, diethylpropion, ephedrine, fenfluramine, flurazepam, mesoridazine,
methamphetamine, norchlordiazepoxide, nordiazepam, oxazepam, phentermine,phenylpropanolamine, prazepam, promazine, thioridazine, thiothixene, trifluoperazine
REFERENCE
Rainin Catalog, Cl-94, 1994, p. 7.24.